163 related articles for article (PubMed ID: 34741003)
1. Evaluation of the Prognostic Role of the Wall Motion Score Index and the SYNTAX Score II in Patients with Acute Coronary Syndrome Following Percutaneous Coronary Intervention by Evaluation of Major Adverse Cardiovascular Events at 12-Month Follow-Up.
Kong F; Xiang L; Wu Y; Tong G
Med Sci Monit; 2021 Nov; 27():e932652. PubMed ID: 34741003
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
[TBL] [Abstract][Full Text] [Related]
3. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Predictive Value of SYNTAX-II Score for Adverse Cardiac Events and Clinical Outcomes in Patients With Acute Coronary Syndrome.
Yuksel Y; Yildiz C; Kose S
Angiology; 2023 Jun; ():33197231181958. PubMed ID: 37295413
[TBL] [Abstract][Full Text] [Related]
5. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
[TBL] [Abstract][Full Text] [Related]
6. Prognostic usefulness of residual SYNTAX score combined with clinical factors for patients with acute coronary syndrome who underwent percutaneous coronary intervention from the SHINANO Registry.
Kashiwagi D; Ebisawa S; Yui H; Maruyama S; Nagae A; Sakai T; Kato T; Saigusa T; Okada A; Motoki H; Kuwahara K
Heart Vessels; 2021 Feb; 36(2):170-179. PubMed ID: 32761363
[TBL] [Abstract][Full Text] [Related]
7. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
[TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study.
Kosaki R; Minoura Y; Ogura K; Oishi Y; Tanaka L; Arai K; Nomura K; Sakai K; Sekimoto T; Nisikura T; Tsujita H; Kondo S; Tsukamoto S; Hamazaki Y; Kobayashi Y
J Cardiol; 2018 Dec; 72(6):494-500. PubMed ID: 29887328
[TBL] [Abstract][Full Text] [Related]
9. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
[TBL] [Abstract][Full Text] [Related]
10. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
Bai XF; Zhang YP; Zhou J; Wu Y; Li RF; Sun LZ; Ma QQ; Lou BW; Zhai BW; Liu MP; Cheng LL; Tong XN; Yuan ZY
Thromb Res; 2018 Oct; 170():142-147. PubMed ID: 30193195
[TBL] [Abstract][Full Text] [Related]
11. Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.
Sebastian G; Pillai V; Manzil A; Damodara R; Kalra I; Abdul Z; Mathew O
Indian Heart J; 2021; 73(5):555-560. PubMed ID: 34627568
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of the SYNTAX score II and the erythrocyte sedimentation rate on long-term clinical outcomes in STEMI patients with multivessel disease: a retrospective cohort study.
Li C; Zhang Q; Wang Q; Zhong J; Wang L; Li K; Yang X
BMC Cardiovasc Disord; 2020 May; 20(1):213. PubMed ID: 32375646
[TBL] [Abstract][Full Text] [Related]
13. SYNTAX score II in patients with coronary artery disease undergoing percutaneous mitral repair with the MitraClip.
Obeid S; Attinger-Toller A; Taramasso M; Pedrazzini G; Suetsch G; Landolt F; Karbeyaz F; Rodriguez H; Sürder D; Moccetti T; Nietlispach F; Maisano F
Int J Cardiol; 2017 Jun; 236():375-380. PubMed ID: 28283362
[TBL] [Abstract][Full Text] [Related]
14. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
Scudeler TL; Farkouh ME; Hueb W; Rezende PC; Campolina AG; Martins EB; Godoy LC; Soares PR; Ramires JAF; Kalil Filho R
BMJ Open; 2022 Sep; 12(9):e062378. PubMed ID: 36137633
[TBL] [Abstract][Full Text] [Related]
15. Association of the SYNTAX Score II with cardiac rupture in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Rencuzogullari I; Çağdaş M; Karabağ Y; Karakoyun S; Yesin M; Gürsoy MO; Seyis S; Artaç İ; İliş D; Efe SÇ; Tanboğa İH
Coron Artery Dis; 2018 Mar; 29(2):97-103. PubMed ID: 29028739
[TBL] [Abstract][Full Text] [Related]
16. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study.
Zhang W; Kong Y; Wang L; Song L; Tan L; Xue X
Medicine (Baltimore); 2020 Aug; 99(33):e20805. PubMed ID: 32871971
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention.
He C; Song Y; Wang CS; Yao Y; Tang XF; Zhao XY; Gao RL; Yang YJ; Xu B; Yuan JQ
Am J Cardiol; 2017 May; 119(10):1493-1499. PubMed ID: 28341359
[TBL] [Abstract][Full Text] [Related]
19. Prognosis evaluation of universal acute coronary syndrome: the interplay between SYNTAX score and ApoB/ApoA1.
Wang X; Wang Z; Li B; Yang P
BMC Cardiovasc Disord; 2020 Jun; 20(1):293. PubMed ID: 32539722
[TBL] [Abstract][Full Text] [Related]
20. Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention.
Xu T; Zhan Y; Lu N; He Z; Su X; Tan X
BMC Cardiovasc Disord; 2017 Dec; 17(1):284. PubMed ID: 29197333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
